1. Home
  2. LGND vs MGEE Comparison

LGND vs MGEE Comparison

Compare LGND & MGEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • MGEE
  • Stock Information
  • Founded
  • LGND 1987
  • MGEE 1855
  • Country
  • LGND United States
  • MGEE United States
  • Employees
  • LGND 68
  • MGEE 717
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • MGEE Electric Utilities: Central
  • Sector
  • LGND Health Care
  • MGEE Energy
  • Exchange
  • LGND Nasdaq
  • MGEE Nasdaq
  • Market Cap
  • LGND 3.2B
  • MGEE 3.1B
  • IPO Year
  • LGND 1992
  • MGEE N/A
  • Fundamental
  • Price
  • LGND $184.49
  • MGEE $83.68
  • Analyst Decision
  • LGND Strong Buy
  • MGEE Sell
  • Analyst Count
  • LGND 8
  • MGEE 2
  • Target Price
  • LGND $144.71
  • MGEE $79.00
  • AVG Volume (30 Days)
  • LGND 139.7K
  • MGEE 149.4K
  • Earning Date
  • LGND 08-05-2025
  • MGEE 11-05-2025
  • Dividend Yield
  • LGND N/A
  • MGEE 2.14%
  • EPS Growth
  • LGND N/A
  • MGEE 12.86
  • EPS
  • LGND N/A
  • MGEE 3.60
  • Revenue
  • LGND $181,488,000.00
  • MGEE $701,317,000.00
  • Revenue This Year
  • LGND $18.41
  • MGEE $10.77
  • Revenue Next Year
  • LGND $18.87
  • MGEE $3.48
  • P/E Ratio
  • LGND N/A
  • MGEE $23.31
  • Revenue Growth
  • LGND 53.40
  • MGEE 8.61
  • 52 Week Low
  • LGND $81.74
  • MGEE $81.14
  • 52 Week High
  • LGND $129.90
  • MGEE $109.22
  • Technical
  • Relative Strength Index (RSI)
  • LGND 79.42
  • MGEE 47.31
  • Support Level
  • LGND $179.40
  • MGEE $82.36
  • Resistance Level
  • LGND $184.26
  • MGEE $84.44
  • Average True Range (ATR)
  • LGND 4.60
  • MGEE 1.35
  • MACD
  • LGND 0.44
  • MGEE 0.00
  • Stochastic Oscillator
  • LGND 100.00
  • MGEE 62.71

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About MGEE MGE Energy Inc

MGE Energy provides electric service to 161,000 customers and natural gas service to 173,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings.

Share on Social Networks: